What is the recommended protocol for patients taking metformin who need an exam with iodinated contrast media?

• A. Continue metformin during the exam
• B. Discontinue metformin for 24 hours
• C. Discontinue metformin for 48 hours before and after
• D. Increase metformin dosage

Answer: (C)

Patients taking metformin, particularly those with renal conditions or undergoing imaging procedures involving iodinated contrast media, require careful management to minimize the risk of contrast-induced nephropathy and potential lactic acidosis. The recommended protocol involves discontinuing metformin for at least 48 hours before the administration of iodinated contrast media and not resuming it until renal function is confirmed to be stable.

This is because iodinated contrast can lead to a decline in kidney function, especially in patients with pre-existing renal impairment. If metformin is continued during this period and there is a reduction in kidney function, there is a risk that lactate may accumulate in the body, leading to lactic acidosis, a serious complication. Thus, this precaution of a 48-hour discontinuation before and after the test is essential to ensure patient safety.

The other options do not align with current guidelines regarding the management of metformin in the context of iodinated contrast media. Continuing metformin during the exam could increase risks, while a shorter discontinuation period of 24 hours is considered insufficient, as residual contrast material may still affect renal function at that time. Increasing the metformin dosage is not a safe practice and could exacerbate potential complications associated with contrast administration.